RxDoctor Payments Data

Lona Haskell, MD

Family Medicine · Huntsville, ALNPI 1023072642

Payments from drug & device makers

$5,623in general payments, 2019–2025

Across 409 payments — averaging $13.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$718
  • Amgen$682
  • AstraZeneca$600
  • Amarin Pharma, Inc.$492
  • Boehringer Ingelheim$477
  • Johnson & Johnson$420
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,612100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,623 in reported general payments places this provider in the 80th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$74,641
Medicare patients
191
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide69$94,126
JardianceEmpagliflozin63$81,457
OzempicSemaglutide53$75,090
JanuviaSitagliptin Phosphate62$63,446
EliquisApixaban37$45,222
MyrbetriqMirabegron55$41,755
TrulicityDulaglutide15$27,175
FarxigaDapagliflozin Propanediol19$24,098
XareltoRivaroxaban12$19,697
Nurtec OdtRimegepant Sulfate16$17,015
RayaldeeCalcifediol13$15,337
InvokanaCanagliflozin15$13,134
LinzessLinaclotide24$12,353
SymbicortBudesonide/Formoterol Fumarate29$9,160
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$8,898

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$254$121,30184 claims
Boehringer IngelheimJardiance$477$81,45763 claims
Novo NordiskOzempic$718$75,09053 claims
MerckJanuvia$243$63,44662 claims
PfizerEliquis, Nurtec Odt$416$62,23753 claims
Astellas Pharma US IncMyrbetriq$17$41,75555 claims
AstraZenecaFarxiga, Symbicort$600$33,25848 claims
Johnson & JohnsonXarelto, Invokana$420$32,83027 claims
AbbVieLinzess, Synthroid$249$17,24971 claims
GSKBreo Ellipta$157$5,49011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →